BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28485547)

  • 1. Pseudoginsenoside-F11 attenuates cerebral ischemic injury by alleviating autophagic/lysosomal defects.
    Liu YY; Zhang TY; Xue X; Liu DM; Zhang HT; Yuan LL; Liu YL; Yang HL; Sun SB; Zhang C; Xu HS; Wu CF; Yang JY
    CNS Neurosci Ther; 2017 Jul; 23(7):567-579. PubMed ID: 28485547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudoginsenoside F11 ameliorates the dysfunction of the autophagy-lysosomal pathway by activating calcineurin-mediated TFEB nuclear translocation in neuron during permanent cerebral ischemia.
    Fu X; Liu Y; Zhang H; Yu X; Wang X; Wu C; Yang J
    Exp Neurol; 2021 Apr; 338():113598. PubMed ID: 33422553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudoginsenoside-F11 Accelerates Microglial Phagocytosis of Myelin Debris and Attenuates Cerebral Ischemic Injury Through Complement Receptor 3.
    Liu Y; Wu C; Hou Z; Fu X; Yuan L; Sun S; Zhang H; Yang D; Yao X; Yang J
    Neuroscience; 2020 Feb; 426():33-49. PubMed ID: 31790669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudoginsenoside-F11 Protects against Transient Cerebral Ischemia Injury in Rats Involving Repressing Calcium Overload.
    Zhang T; Wu C; Yang X; Liu Y; Yang H; Yuan L; Liu Y; Sun S; Yang J
    Neuroscience; 2019 Jul; 411():86-104. PubMed ID: 31129202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RIP1K Contributes to Neuronal and Astrocytic Cell Death in Ischemic Stroke via Activating Autophagic-lysosomal Pathway.
    Ni Y; Gu WW; Liu ZH; Zhu YM; Rong JG; Kent TA; Li M; Qiao SG; An JZ; Zhang HL
    Neuroscience; 2018 Feb; 371():60-74. PubMed ID: 29102662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudoginsenoside-F11 improves long-term neurological function and promotes neurogenesis after transient cerebral ischemia in mice.
    Yuan L; Sun S; Pan X; Zheng L; Li Y; Yang J; Wu C
    Neurochem Int; 2020 Feb; 133():104586. PubMed ID: 31756514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudoginsenoside-F11 promotes functional recovery after transient cerebral ischemia by regulating the microglia/macrophage polarization in rats.
    Hou Y; Yang D; Wang X; Wang H; Zhang H; Wang P; Liu Y; Gao X; Yang J; Wu C
    Int Immunopharmacol; 2021 Oct; 99():107896. PubMed ID: 34246061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pseudoginsenoside-F11 ameliorates ischemic neuron injury by regulating the polarization of neutrophils and macrophages in vitro.
    Hou Y; Yang D; Zhang Q; Wang X; Yang J; Wu C
    Int Immunopharmacol; 2020 Aug; 85():106564. PubMed ID: 32447220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effect of pseudoginsenoside-F11 on permanent cerebral ischemia in rats by regulating calpain activity and NR2A submit-mediated AKT-CREB signaling pathways.
    Liu Y; Fu X; Liu Y; Zhang T; Cui P; Wang S; Liu L; Hou Z; Wang H; Zhao Y; Zhang Z; Zhang H; Wu C; Yang J
    Phytomedicine; 2022 Feb; 96():153847. PubMed ID: 34836744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudoginsenoside-F11 alleviates oligomeric β-amyloid-induced endosome-lysosome defects in microglia.
    Yao XC; Xue X; Zhang HT; Zhu MM; Yang XW; Wu CF; Yang JY
    Traffic; 2019 Jan; 20(1):61-70. PubMed ID: 30375163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudoginsenoside-F11 ameliorates thromboembolic stroke injury in rats by reducing thromboinflammation.
    Gao Y; Liu Y; Yang X; Zhang T; Hou Y; Wang P; Liu Y; Yuan L; Zhang H; Wu C; Yang J
    Neurochem Int; 2021 Oct; 149():105108. PubMed ID: 34175350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuronal-targeted TFEB rescues dysfunction of the autophagy-lysosomal pathway and alleviates ischemic injury in permanent cerebral ischemia.
    Liu Y; Xue X; Zhang H; Che X; Luo J; Wang P; Xu J; Xing Z; Yuan L; Liu Y; Fu X; Su D; Sun S; Zhang H; Wu C; Yang J
    Autophagy; 2019 Mar; 15(3):493-509. PubMed ID: 30304977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuronal injury in rat model of permanent focal cerebral ischemia is associated with activation of autophagic and lysosomal pathways.
    Wen YD; Sheng R; Zhang LS; Han R; Zhang X; Zhang XD; Han F; Fukunaga K; Qin ZH
    Autophagy; 2008 Aug; 4(6):762-9. PubMed ID: 18567942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postischemic treatment of neonatal cerebral ischemia should target autophagy.
    Puyal J; Vaslin A; Mottier V; Clarke PG
    Ann Neurol; 2009 Sep; 66(3):378-89. PubMed ID: 19551849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudoginsenoside-F11 (PF11) exerts anti-neuroinflammatory effects on LPS-activated microglial cells by inhibiting TLR4-mediated TAK1/IKK/NF-κB, MAPKs and Akt signaling pathways.
    Wang X; Wang C; Wang J; Zhao S; Zhang K; Wang J; Zhang W; Wu C; Yang J
    Neuropharmacology; 2014 Apr; 79():642-56. PubMed ID: 24467851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvianolic acid B attenuates apoptosis and inflammation via SIRT1 activation in experimental stroke rats.
    Lv H; Wang L; Shen J; Hao S; Ming A; Wang X; Su F; Zhang Z
    Brain Res Bull; 2015 Jun; 115():30-6. PubMed ID: 25981395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ginkgo biloba extract (EGb-761) confers neuroprotection against ischemic stroke by augmenting autophagic/lysosomal signaling pathway.
    Zang R; Ling F; Wu Z; Sun J; Yang L; Lv Z; Ji N
    J Neuroimmunol; 2023 Sep; 382():578101. PubMed ID: 37536050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of histone H4 lysine 16 acetylation (H4K16ac) elicits a neuroprotection against ischemic stroke by alleviating the autophagic/lysosomal dysfunction in neurons at the penumbra.
    Lingling D; Miaomiao Q; Yili L; Hongyun H; Yihao D
    Brain Res Bull; 2022 Jun; 184():24-33. PubMed ID: 35351588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chloroquine exerts neuroprotection following traumatic brain injury via suppression of inflammation and neuronal autophagic death.
    Cui CM; Gao JL; Cui Y; Sun LQ; Wang YC; Wang KJ; Li R; Tian YX; Cui JZ
    Mol Med Rep; 2015 Aug; 12(2):2323-8. PubMed ID: 25872478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
    Shi QJ; Wang H; Liu ZX; Fang SH; Song XM; Lu YB; Zhang WP; Sa XY; Ying HZ; Wei EQ
    Neuroscience; 2015 Apr; 291():53-69. PubMed ID: 25681271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.